4.8 Article

A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology

期刊

CANCER RESEARCH
卷 76, 期 24, 页码 7151-7159

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-16-1624

关键词

-

类别

资金

  1. Health Research Council of New Zealandgrant
  2. Royal Society of New Zealand Marsden Fund
  3. Maurice Wilkins Centre, New Zealand
  4. Cancer Council of New South Wales, Australia

向作者/读者索取更多资源

TP53 undergoes multiple RNA-splicing events, resulting in at least nine mRNA transcripts encoding at least 12 functionally different protein isoforms. Antibodies specific to p53 protein isoforms have proven difficult to develop, thus researchers must rely on the transcript information to infer isoform abundance. In this study, we used deep RNA-seq, droplet digital PCR (ddPCR), and real-time quantitative reverse transcriptase PCR (RT-qPCR) from nine human cell lines and RNA-seq data available for tumors in The Cancer Genome Atlas to analyze TP53 splice variant expression. All three methods detected expression of the FL/40TP53 alpha_T1 variant in most human tumors and cell lines. However, other less abundant variants were only detected with PCR-based methods. Using RNA-seq simulation analysis, we determined why RNA-seq is unable to detect less abundant TP53 transcripts and discuss the implications of these findings for the general interpretation of RNA-seq data. (C)2016 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据